home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Japan - Regulatory Filing Requirements and Compliance Processes for Life Sciences - Part I and Part II - Webinar By GlobalCompliancePanel

 
  November 26, 2010  
     
 
GlobalCompliancePanel, Online Training
2011-01-18


Overview: This course specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products in Japan.

.style3 { font-size: 16px; font-weight: bold; } The course will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies in Japan. Content will also include descriptions of the methods by which regulators in the corresponding agencies process filings and registrations and what is expected in the authorization and dossier maintenance of licensed products.

The current regulatory climate will be discussed in depth and several examples will be provided to illustrate effective compliance procedures and techniques. Common issues which have caused difficulties for Life Sciences firms will also be discussed. Course content will also explain how Japan interacts with and utilizes ICH standards and how they relate with other national regulatory agencies. The course will also discuss how personnel can best address the conflicts that sometimes arise and the approach that can best be taken for resolution.

Agenda for Part I:

Japan - Understanding the Dynamics of the Changing Structure, Regulatory Requirements and Compliance Processes for Life Science Products
  • Japan's Regulatory Structure for the Life Science Product Industries
    • Demographic Overview
    • Regulatory Framework:  Key Agencies Involved / Reporting Structure
    • Recent Changes to MHLW / PMDA to Speed Review
      • MHLW (Ministry of Health, Labour and Welfare)
      • PMDA  (Pharmaceutical and Medical Device Agency)
      • PAFSC (Pharmaceutical Affairs and Food Sanitation Council)
    • Patents and Trademark Considerations
  • Beginning Your Company Involvement in Japan
    • Local Office and Personnel Requirement Options
    • Language Requirements
    • Possible License Types
  • Objectives of the Rules Governing Medicinal Procedures
    • Market Authorization Holder Overview
  • Life Science Regulations and the Regulatory Processes in Japan
    • Pre-Clinical
    • Conducting Clinical Trials
    • New Product Registrations & Filings
    • Post-Marketing Requirements
    • Pricing & Reimbursement
  • Japan's Use of ICH Standards / Principles
    • GCP
    • GMP
    • CTD / e-CTD Submissions
  • Starting-Up and Conducting Clinical Trials
    • Clinical Trial Start-Up process
      • Japan's Effort to Reduce "The Drug Lag"
      • Japan's Desire to Eliminate Bridging Studies and Participate in Ph. III Global Trials
Agenda for Part II:

Japan - Understanding the Dynamics of the Changing Structure, Regulatory Requirements and Compliance Processes for Life Science Products
  • Marketing Authorization Processes – Filings & Registrations
    • Pharmaceutical Affairs Law (PAL) & Drug Registration
    • Medical Devices
    • Biologic Considerations
    • Developing Combination Products; Classification and Licensing Review
    • Drug Master File (DMF) Use in Japan
    • Labeling Requirements
    • Package Insert Requirements
  • Variations: Changes to Marketed Products
    • Types of Variations
    • Variation Filings and Typical Review Times
  • License Renewals
    • Japan's Process; What has recently changed
    • License Terms
    • Maintenance Responsibilities
  • Comparing and Contrasting Japan’s Procedures vs. U.S. FDA
    • Comparison of Processes
    • Agency Interactions
    • Accepted Practices
  • How and When to Influence the Regulatory Process
    • Japanese Way of Thinking / Coming to Agreement
    • Important Cultural Issues for Consideration
    • The Do's and Don'ts of Regulatory Involvement in Japan
  • How to Use Regulations / Regulatory Contacts to Your Advantage
    • Agency Interactions
    • Business Impact Within and Outside of Japan
    • Professionalism in Regulatory Affairs

Who Will Benefit: This course will also be useful for sales or general management personnel who need an overview of the Regulatory Compliance requirements within Japan and how best to consider the country into one's Business Strategy.

  • Regulatory personnel whose responsibilities require knowledge of Japan's regulatory environment.
  • Administrative staff responsible for ensuring compliance with regulatory filings and overall regulatory compliance requirements will also find this training highly relevant.
  • Any sales or general management employee requiring an understanding of how regulations and compliance issues impact the organization will also benefit.
 
 
Organized by: GlobalCompliancePanel
Invited Speakers: For the past 9 years, Bob has been President of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with International Regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington, DC, Brussels, Belgium with exclusive affiliates across Asia and Latin America. Bob has 28 years of past industry experience as a CMC specialist, R&D Director and Global Director of Regulatory Affairs for Merion Merrill Dow pharmaceuticals and Cordis-Dow medical devices. He has a BS / MS degree in Chemistry.
 
Deadline for Abstracts: 2011-01-18
 
Registration:
Tuesday, January 18, 2011  
10:00 AM PST | 01:00 PM EST
Live live online training only for one participant
Price: $395.00
 
 
 
Corporate Live 4 to 10 participants from a single location (For multiple locations contact Customer Care)
Price: $1,195.00
 

Recorded Access recorded version only for one participant; unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Price: $465.00
E-mail: webinars@globalcompliancepanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.